|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Bitcoin mining | |||||
| Commissions | |||||
| Online sales, net | |||||
| Rental income | |||||
| Total revenue | |||||
| Cost of revenues - energy, hosting, and other | |||||
| Costs and expenses: | |||||
| Selling and marketing | |||||
| Cost of revenues - online products | |||||
| Cost of revenues - rent | |||||
| General and administrative | |||||
| Change in fair value of digital assets | |||||
| Realized (gain) loss on sale/purchase of digital assets | |||||
| Depreciation and amortization | |||||
| Realized gain (loss) on sale/purchase of digital assets | |||||
| Loss on disposition of property and equipment | |||||
| Impairment of property and equipment | |||||
| Realized (gain) loss on sale/purchase of digital assets | |||||
| Impairment expense | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Loss on exercise of warrant | |||||
| Other income | |||||
| Interest expense | |||||
| Loss on settlement of payables | |||||
| Loss on exchange of Series C & D preferred shares | |||||
| Total other income (expense) | |||||
| Income (loss) from continued operations before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) from continued operations | |||||
| Net income (loss) from discontinued operations | |||||
| Net income (loss) | |||||
| Net income (loss) attributable to noncontrolling interest | |||||
| Net income (loss) attributable to MedWellAI, Inc. | |||||
| Dividends on Preferred Stock | |||||
| Deemed dividend | |||||
| Net income (loss) attributable to shareholders | |||||
| Net loss per common share attributable to shareholders, basic | |||||
| Net income (loss) per common share attributable to shareholders, basic | |||||
| Net income (loss) per common share attributable to shareholders, diluted | |||||
| Weighted average number of common shares outstanding, basic | |||||
| Weighted average number of common shares outstanding, diluted | |||||
| Discontinuing operations: | |||||
| Net income (loss) per common share attributable to shareholders, basic | |||||
| Net income (loss) per common share attributable to shareholders, diluted | |||||
| Weighted average number of common shares outstanding, basic | |||||
| Weighted average number of common shares outstanding, diluted | |||||
Loading...